• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Compass Therapeutics Inc (NQ: CMPX )

    1.090 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.090
    Bid (Size) 1.100 (40)
    Ask (Size) 1.130 (5)
    Prev. Close 1.090
    Today's Range 1.090 - 1.090
    52wk Range 0.7650 - 3.010
    Shares Outstanding 127,486,326
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024
    CMPX stock results show that Compass Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -26.35%
    -26.35%
    1 Month
    +15.28%
    +15.28%
    3 Month
    -25.34%
    -25.34%
    6 Month
    -24.31%
    -24.31%
    1 Year
    -62.02%
    -62.02%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Recap: Compass Therapeutics Q3 Earnings
    Via Benzinga
    Compass Therapeutics: Q1 Earnings Insights
    Via Benzinga
    Expert Ratings for Compass Therapeutics
    Via Benzinga
    3 Penny Stocks With the Power to 10X Your $1K Investment
    Via InvestorPlace
    CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition
    Via InvestorPlace
    Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
    Via Benzinga
    Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
    Via Benzinga
    Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.